Abstract
The ability to remember emotionally significant stimuli and stimulus associations is critical to survival, as it ensures that rewarding and threatening events can be recalled to guide future behavior. Consequently, events are consolidated more strongly into long-term memory as they are encoded under heightened emotional arousal. Such memory prioritization is partly driven by the release of peripheral adrenaline, which acts as a bodily signal emphasizing an event’s emotional significance and enhances plasticity in the brain. Animal research suggest that the vagus nerve translates elevated peripheral adrenaline into central noradrenergic activation of memory-relevant brain areas via its projections to the brainstem locus coeruleus–the main source of noradrenaline in the brain. The possibility of vagus nerve stimulation (VNS), both invasively (iVNS) and non-invasively (i.e., transcutaneously; tVNS), has opened up new avenues to test a potential vagal route to memory in humans whilst circumventing the necessity of actual peripheral adrenergic release. Here, we briefly review recent research applying iVNS and tVNS in a variety of animal and human emotional episodic memory and Pavlovian conditioning and extinction learning experiments, supporting a critical role of the vagus nerve in modulating emotional memories. Based on this body of evidence, we highlight clinical areas where VNS may therefore serve as an adjunct to treatments for neurocognitive, anxiety- and trauma-related disorders, that aim at improving learning and memory consolidation. In fact, a brief review of (sub-) clinical studies shows that VNS alleviates symptoms in mild cognitive impairment, Alzheimer’s disease as well as anxiety- and trauma-related disorders.
Introduction
Memories are created through a highly selective filter: While mundane experiences easily fade away, events laden with emotional salience are etched deeply into our remembrance (; LaBar and Cabeza, 2006; Wang and Bukuan, 2015; Rouhani et al., 2023). Emotions are typically elicited during events that are critical to our survival and can therefore functionally be conceived as tags emphasizing the motivational significance of stimuli and stimulus associations (). Thus, memory prioritization for emotional material is highly adaptive, as it ensures that significant events (e.g., receiving rewards or facing threats) can be recalled to guide our future behavior (e.g., approach or escape) (McIntyre et al., 2012; ; Szeska et al., 2022). Given its relevance, it may therefore be somewhat surprising that the memory-enhancing effect of emotion has been recognized for a long time (James, 1890), yet the underlying mechanisms of action have only begun to be uncovered in the second half of the last century ().
More than 50 years later, it is now well established that memory consolidation for emotional experiences is prioritized as they are associated with a profound increase in arousal, entailing increased attentional and perceptual processing (; LaBar and Cabeza, 2006; Rouhani et al., 2023). For instance, pictures that have been rated as highly arousing are overall better remembered than low arousing ones, as indicated by increased free recall (; Hamann et al., 1997) and high-confidence (recollection-based) recognition memory (, ; Weymar et al., 2009). Even non-emotional pictures of tools or animals have found to be preferably consolidated if they have been associated with physiologically arousing stimuli, e.g., an aversive electric shock or a monetary reward (; Patil et al., 2017). Accordingly, dedicated strategies that elevate arousal around the time of stimulus encoding, e.g., by stressful tasks, have found to additionally foster memory enhancement for emotional material (Nielson et al., 1996; Nater et al., 2007; Schwabe et al., 2008; Weymar et al., 2012), while strategies that decrease arousal, e.g., by relaxing music, have shown to attenuate such effect (Rickard et al., 2012; for a review see McGaugh, 2018).
Extensive research in animals and humans unveiled that arousal-based memory enhancement is hinged upon the adrenal glands’ immediate adrenaline and delayed glucocorticoids release (Roozendaal et al., 2009; McIntyre et al., 2012; McGaugh, 2018). For instance, aversive emotionally arousing pictures (e.g., of a snake or a gun pointing towards the participant; see Figure 1) lead to a profound increase in peripheral adrenergic activation, as indexed by endocrine markers such as salivary alpha amylase (sAA), and cortisol release, both of which positively covarying with enhanced memory retention (; ; Van Stegeren et al., 2006; Segal and Cahill, 2009). Highlighting the particular role of adrenergic activation in memory consolidation, depleted levels of peripheral adrenaline–e.g., due to adrenalectomy–in contrast impair memory performance for emotional stimuli (). Providing even stronger mechanistic evidence, small doses of exogeneous adrenaline foster memory enhancement for emotional material and even reverse the effects of adrenalectomy (; ), while beta-blockers that attenuate adrenergic transmission prevent memory enhancement from unfolding (Van Stegeren et al., 1998; for electrocortical evidence see e.g., Weymar et al., 2010).
FIGURE 1
Pharmacological and imaging studies have demonstrated, that increased levels of peripheral adrenaline invoke such memory enhancement by impacting on the neural transmission in the amygdala–a central hub organizing the establishment of emotional memories via its projections to the hippocampus and cortical regions (; Kensinger, 2004; Ritchey et al., 2008; McIntyre et al., 2012; McGaugh, 2018). Accordingly, the activity of this region during encoding of emotionally arousing material increases and positively correlates with memory performance (; Figure 1), while bilateral amygdala lesions have found to prevent memory enhancement for emotionally salient stimuli (; Phelps et al., 1998). At this, increases in amygdala activity are indeed strikingly concomitant to increases in adrenergic activity (Van Stegeren et al., 2006; van Stegeren et al., 2007), suggesting that the release of adrenaline might stimulate this region to ultimately invoke memory enhancement: In line with this view, direct infusions of adrenaline into the amygdala foster, while direct infusions of beta-blockers attenuated emotional memory enhancement in animals (Liang et al., 1995).
However, as peripheral adrenaline is unable to cross the blood-brain barrier (Weil-Malherbe et al., 1959), a neural axis–the vagus nerve-has been presumed to convey information about elevated adrenergic levels from the body to the brain, thereby indirectly increasing neural transmission in memory-relevant brain regions. The vagus nerve, as a cranial nerve consisting of 80% afferent fibers, had long been considered a major autonomic communication route by which the brain receives information about the state of the inner body (Foley and DuBois, 1937; ; McIntyre et al., 2012). Importantly, vagal afferents indeed innervate the adrenal glands and are highly responsive to the release of peripheral adrenaline due to a high number of beta-adrenergic receptors (; Niijima, 1992; Miyashita and Williams, 2006; Figure 1). Thus, the release of peripheral adrenaline is able to activate vagal afferents, which then project to the nucleus of the solitary tract (NTS) in the brainstem where adrenergic activation is finally synapsed onto the main hub of noradrenaline in the brain: the locus coeruleus (LC) (Miyashita and Williams, 2004; McIntyre et al., 2012; McGaugh, 2018; Figure 1). By way of the vagus nerve, a peripheral release of adrenaline is thus translated into increased noradrenergic release via the LC-brainstem arousal system. This system ultimately projects to memory-relevant brain areas including the basolateral amygdala (AMY), hippocampus (HC) and cortex (e.g., the medial prefrontal cortex; mPFC), increasing noradrenergic transmission and, thus, promoting plasticity in these areas to eventually foster memory establishment (McIntyre et al., 2012; Mather et al., 2016; McGaugh, 2018; Figure 1). Accordingly, the vagus nerve was presumed to constitute the first relay of a neural circuit mediating the memory enhancing effects of emotional arousal. Indeed, animal research supports this concept by showing that an invasive stimulation of the vagus nerve (iVNS) elicits firing in the NTS and LC and eventually increases noradrenergic transmission in the amygdala (Hassert et al., 2004; Hulsey et al., 2017; ). Consequently, iVNS in fact promotes the memory formation in animals () while such memory enhancement is prohibited from unfolding, when the LC is optogenetically silenced ().
While a major role of the vagus nerve in the formation of emotional memories is thus supported by the animal model (see for a review Olsen et al., 2023), a comparable role has long been elusive in humans. In 1999, however, Clark and colleagues demonstrated that iVNS in fact leads to an enhancement in word recognition memory (). Despite such promising preliminary evidence, though, subsequent stimulation studies that further explored a vagal route to memory in humans remained scarce due to the requirement of invasive surgery. This changed at the beginning of the millennium, when Peuker and Filler (2002) discovered that vagal afferents reach the body’s surface at the Cymba Conchae of the human auricle – a skin area that is exclusively innervated by the auricular vagal branch (Figure 1), allowing non-invasive vagal stimulation (transcutaneous auricular vagus nerve stimulation; taVNS) with minimal side effects (Giraudier et al., 2025). TaVNS leads to activation in the vagal afferent network important for memory formation including the NTS, LC, amygdala, hippocampus and mPFC, and also results in an increase in central noradrenergic transmission (Frangos et al., 2015; Yakunina et al., 2017; Ventura-Bort et al., 2018; Sclocco et al., 2019; ; Teckentrup et al., 2021; Giraudier et al., 2022; Figure 1). The availability of this neuromodulatory strategy has opened up new possibilities to test whether the vagus nerve fulfils a similar role for emotional memory in humans as it does in animals. In the following sections, we will provide a brief overview of recent stimulation studies, which support the view that vagal firing promotes episodic and associative emotional memory establishment. Based on this body of evidence, we will highlight potential areas of clinical application where VNS may be utilized to facilitate the long-term consolidation of learning experiences.
The role of the vagus nerve in episodic memory
Initial evidence for the causal influence of ascending vagal fibers in emotional memory came from animal research (, ). In one study, trained rats in an inhibitory avoidance task, where animals were to learn to avoid an electric shock. Directly after, animals received either 30 s of VNS or sham stimulation (see Table 1). The authors observed that VNS compared to sham stimulation improved memory performance, assessed 24 h after stimulation, especially for intermediate stimulation intensities (; see also Sanders et al., 2019; Olsen et al., 2022; for a review see Olsen et al., 2023; also see Table 1). Subsequent studies have shown that VNS modulates molecular mechanisms within the HC, suggesting that VNS-induced memory improvements are likely related to hippocampal activity (c.f., Olsen et al., 2023).
TABLE 1
| Stimulation parameters | ||||||||||||
| Authors | Topic | Subject | VNS type | VNS site | Fre-quency | Pulse width | Duty cycle | Duration per session* | Intensity | Timing | Task | VNS effect |
| Episodic memory | Animal | iVNS | Left | 20 Hz | 500 μs | continuous | 30 s | 0.2/0.4/0.8 mA | After encoding | Inhibitory avoidance | Improved memory retention for 0.4 mA of stimulation | |
| Episodic memory | Animal | iVNS | Left | 20 Hz | 500 μs | continuous | 30 s | 0.2/0.4/0.8 mA | After encoding | Inhibitory avoidance | Improved memory retention for 0.4 mA of stimulation | |
| Sanders et al., 2019 | Episodic memory | Animal | iVNS | Left | 30 Hz | 100 μs | Intermittent 0.5 s trains | Effective stimulation duration ∼ 51 s | 0.8 mA | During multiple encoding sessions | Object recognition | Increased novelty preference as an index of improved memory retention |
| Episodic memory | Human (epileptic patients) | iVNS | Left | 30 Hz | 500 μs | continuous | 30 s | 0.50 mA, 0.75 –1.50 mA | After encoding | Word recognition | Improved recognition memory for 0.50 mA of stimulation | |
| Olsen et al., 2022 | Episodic memory | Animal | iVNS | Left | 30 Hz | 100 μs | Intermittent 0.5 s trains | Effective stimulation duration ∼ 50 s | 0.8 mA | During encoding | Inhibitory avoidance and object recognition | Improved memory performance in both tasks |
| Mertens et al., 2022 | Episodic memory | Human (epileptic patients) | iVNS and taVNS | Left | 30 Hz | 500 μs | continuous | 30 s | invasive 0.5/1.0 mA (increased by 0.125 and 0.25 mA throughout treatment) non-invasive: individually adjusted | After encoding | Word recognition | No immediate memory improvement. However, improved memory retention after 6 weeks of VNS |
| Ghacibeh et al., 2006 | Episodic memory | Human (epileptic patients) | iVNS | Left | No report | No report | continuous | 30 s | 0.5 mA | During encoding | Word recall | Improved memory retention |
| Ventura-Bort et al., 2021 | Episodic memory | Human | taVNS | Left | 25 Hz | 250 μs | continuous | 7 min | individually adjusted | During encoding | Picture recognition | Improved high-confidence recognition memory for emotional pictures | Enhanced electrocortical correlates of emotional encoding and memory retrieval |
| Ludwig et al., 2025 | Episodic memory | Human | taVNS | Left | 25 Hz | 250 μs | Intermittent 3 s trains | Effective stimulation duration 2.4 min | 3.0 mA/5.0 mA | During encoding | Picture recognition | Improved recognition memory for emotional pictures |
| Ventura-Bort et al., 2025 (Exp. 1) | Episodic memory | Human | taVNS | Left | 25 Hz | 250 μs | Intermittent 30 s trains | Effective stimulation duration 7.5 min | individually adjusted | During and after encoding | Picture recognition | No effect on memory performance | Enhanced electrococortical correlates of emotional encoding and memory retrieval in taVNS condition |
| Ventura-Bort et al., 2025 (Exp. 2) | Episodic memory | Human | taVNS | Left | 25 Hz | 250 μs | Intermittent 30 s trains | Effective stimulation duration 7.5 min | individually adjusted | During encoding | Picture recognition | Improved high-confidence recognition memory for emotional pictures | Enhanced electrocortical correlates of emotional encoding and memory retrieval |
| Giraudier et al., 2020 | Episodic memory | Human | taVNS | Left | 25 Hz | 250 μs | Intermittent 30 s trains | Effective stimulation duration 11.5 min | individually adjusted | Before, during and after encoding | Word recognition | Improved high-confidence recognition memory for neutral and emotional words |
| Mertens et al., 2020 | Episodic memory | Human | taVNS | No report | 25 Hz | 250 μs | continuous | 30 s | 0.5 mA and individually adjusted | After encoding | Word recognition | No effect of taVNS |
| Peña et al., 2013 | Associative memory | Animal | iVNS | Left | 20 Hz | 500 μs | intermittent 30 s trains | Effective stimulation duration 2 min | 0.4 mA | During extinction | Single-cue fear conditioning and extinction | Improved fear extinction learning and memory retention |
| Peña et al., 2014 | Associative memory | Animal | iVNS | Left | 30 Hz | 500 μs | intermittent 30 s trains | Effective stimulation duration 2 min | 0.4 mA | During extinction | Single-cue fear conditioning and extinction | Improved between-session extinction/equivalent to extended extinction |
| Associative memory | Animal | iVNS | Left | 20 Hz | 500 μs | intermittent 30 s trains | Effective stimulation duration 2 min | 0.4 mA | During initial extinction | Single-cue fear conditioning and extinction | Improved between-session extinction | |
| Noble et al., 2017 | Associative memory | Animal (PTSD model) | iVNS | Left | 20 Hz | 100 μs | intermittent 30 s trains | Effective stimulation duration 2 min | 0.4 mA | During multiple extinction sessions | Single-cue fear conditioning and extinction | Improved between-session extinction, reversal of extinction impairments and attenuation of PTSD-like symptoms due to prior prolonged stress |
| Noble et al., 2019 | Associative memory | Animal | iVNS | Left | 20 Hz | 100 μs | intermittent 30 s trains | Effective stimulation duration 2 min | 0.4 mA | During multiple extinction sessions | Single-cue fear conditioning and extinction | Improved between-session extinction; Improved extinction memory generalization; Inherent anxiolytic effects of VNS |
| Souza et al., 2019 | Associative memory | Animal (PTSD model) | iVNS | Left | 30 Hz | 100 μs | intermittent 30 s trains | Effective stimulation duration 2.5 min | 0.4 mA | During multiple extinction sessions | Fear conditioning and extinction | Improved between-session extinction, reduced fear renewal and inherent anxiolytic effects of VNS |
| Souza et al., 2021 | Associative memory | Animal (PTSD model) | iVNS | Left | 30 Hz | 100 μs | intermittent 0.5 s trains | Effective stimulation duration 10 s | 0.4/0.8/1.6 mA | During multiple extinction sessions | Single-cue fear conditioning and extinction | Improved between-session extinction at 0.4 and 0.8 mA, improved long-term extinction retention at 0.8 mA, no extinction enhancement at 1.6 mA |
| Souza et al., 2022 | Associative memory | Animal | iVNS | Left | 30 Hz | 100 μs | intermittent 0.5 s trains | Effective stimulation duration up to 40 s | 0.5/0.8 mA | During multiple extinction sessions | Single-cue fear conditioning and extinction | Strong vs. modest between-session extinction improvements when stimulation was paired vs. unpaired with CS, respectively |
| Associative memory | Animal | iVNS | Left | 30 Hz | 500 μs | intermittent 2 s trains | Effective stimulation duration 32 s | 0.8 mA | During initial extinction | Single-cue fear conditioning and extinction | Facilitated between-session extinction | |
| Associative memory | Animal | iVNS | Left | 30 Hz | 100 μs | intermittent 0.5 s trains | Unclear | 0.8 mA | During multiple extinction sessions | Extinction of cocaine seeking | Facilitated between-session extinction and reduced reinstatement of cocaine seeking | |
| (Exp. 1) | Associative memory | Animal | iVNS | Left | 30 Hz | 500 μs | Intermittent 30 s trains | Effective stimulation duration 3 min | 0.4 mA | During or after multiple extinction sessions | Conditioned place preference and extinction | Reduced reinstatement of conditioned place preference for cocaine |
| (Exp. 2) | Associative memory | Animal | iVNS | Left | 30 Hz | 500 μs | Intermittent 30 s trains | Unclear | 0.4 mA | During multiple extinction sessions | Extinction of cocaine seeking | Enhanced extinction from drug seeking, reduced context- and cue-induced reinstatement of cocaine seeking |
| Associative memory | Human | taVNS | Left | 25 Hz | No report | Intermittent 30 s trains | Unclear | 0.5 mA | During initial extinction | Differential-cue fear conditioning and extinction | Facilitated within-session extinction (threat expectancy), no effect on extinction recall | |
| Associative memory | Human | taVNS | Left | 25 Hz | 250 μs | Intermittent 30 s trains | Effective stimulation duration 10 min | 0.5 mA | During initial extinction | Differential-cue fear conditioning and extinction | Facilitated within-session extinction (threat expectancy), no effect on extinction recall | |
| Associative memory | Human | taVNS | Left | 25 Hz | 250 μs | Intermittent 30 s trains | Effective stimulation duration ∼ 13 min | 0.5 mA | During initial extinction | Differential-cue fear conditioning and extinction | No effect of taVNS | |
| Szeska et al., 2020 | Associative memory | Human | taVNS | Left | 25 Hz | 250 μs | Intermittent 30 s trains | Effective stimulation ∼ 4 min | individually adjusted | During initial extinction | Single-cue fear conditioning and extinction | Facilitated within-session extinction and between-session extinction (threat expectancy, startle response) |
| Szeska et al., 2021 | Associative memory | Human | taVNS | Left | 25 Hz | 250 μs | Intermittent 30 s trains | Effective stimulation ∼ 4 min | individually adjusted | During initial extinction | Single-cue fear conditioning and extinction | Facilitated within-session extinction (heart rate) |
| Associative memory | Human | taVNS | Left | 25 Hz | 250 μs | continuous | Effective stimulation duration ∼ 15 min | individually adjusted | During initial extinction | Differential-cue fear conditioning and extinction | No effect of taVNS | |
| Genheimer et al., 2017 | Associative memory | Human | taVNS | Left | 25 Hz | 250 μs | Intermittent 30 s trains | Effective stimulation duration ∼ 20 min | individually adjusted | Before and during initial extinction | Contextual fear conditioning and extinction | No effects of taVNS |
| Jacobs et al., 2015 | MCI and AD | Human (elderly) | taVNS | Left | 8 Hz | 200 μs | continuous | Effective stimulation duration 17 min | 5.0 mA | During and after encoding | Face-Name assocation task | Improved recognition memory |
| Murphy et al., 2023 | MCI and AD | Human (MCI) | taVNS | Left | 20 Hz | 50 μs | continuous | Effective stimulation duration 6 min | individually adjusted | During MRI scanning | Resting State MRI | Altered functional connectivity between brain regions involved in semantic and salience processing |
| Wang et al., 2022 | MCI and AD | Human (MCI) | taVNS | Left | 20 Hz and 50 Hz | No report | continuous | Effective stimulation duration 30 min | individually adjusted | Between baseline and follow-up testing (after 24 weeks of treatment) | Battery of cognitive tests | Improved cognitive (including memory) performance |
| MCI and AD | Human (MCI) | taVNS | Left | Unclear | Unclear | Unclear | Unclear | Unclear | Unclear | Face-Name assocation task | Improved recognition memory | |
| Sjogren et al., 2002 | MCI and AD | Human (AD patients) | iVNS | Left | 20 Hz | No report | intermittent 30 s trains | Unclear | 0.25 mA (increased throughout treatment to 0.5 mA) | After baseline and during follow-up testing (at 3 and 6 months of treatment) | Battery of cognitive tests | Improved cognitive performance after 3 and 6 months of VNS treatment |
| Merrill et al., 2006 | MCI and AD | Human (AD patients) | iVNS | Left | 20 Hz | No report | intermittent 30 s trains | Unclear | 0.25 mA (increased throughout treatment to 0.5 mA) | After baseline and during follow-up testing (1 year after treatment) | Battery of cognitive tests | Improved cognitive performance after 1 year of VNS treatment |
| Powers et al., 2025 | PTSD and Anxiety disorders | Humans (treatment-resistant PTSD patients) | iVNS | Left | 30 Hz | 100 μs | intermittent 0.5 s trains | Unclear | 0.8 mA | During prolonged exposure sessions | Repeated prolonged exposure sessions (therapist guided and alone) | Alleviation of PTSD symptoms lasting for at least 6 months, loss of PTSD diagnosis |
| Szeska et al., 2025 | PTSD and Anxiety disorders | Humans (spider phobic individuals) | taVNS | Left | 25 Hz | 250 μs | Intermittent 30 s trains | Effective stimulation duration ∼ 11 min | individually adjusted | During laboratory exposure to spider pictures | Repeated in vivo exposures separated by one in vitro laboratory exposure | Inhibition of stimulus-specific threat responses (heart rate, corrugator activity), reduced avoidance behavior towards exposed tarantula |
Overview of reviewed studies with particular emphasis on critical stimulation parameters and central effects.
*The application duration may differ substantially from effective stimulation duration (e.g., upon long inter-stimulation intervals). Also note, that the effective stimulation duration may accumulate, if there are multiple VNS sessions per day.
In a follow up study, attempted to extend their animal findings to humans. In this study, epileptic patients with an implanted VN stimulator underwent verbal learning before receiving either active VNS at varying intensities (Table 1) or no stimulation in a control condition. Memory performance was tested in an immediate word-recognition test. Results showed that when the stimulation device was turned on after encoding, participants exhibited better memory performance, compared to when the stimulator remained off, particularly at intermediate stimulation intensities (). Subsequent investigations on the effects of iVNS on memory performance have, however, yielded mixed findings. While some studies also reported positive effects of iVNS on memory performance (Ghacibeh et al., 2006), others failed to observed memory improvements after iVNS (Mertens et al., 2022; for a review see Olsen et al., 2023; see Table 1).
Unlike animal studies, which focused on emotional memories, human studies using iVNS did not assess episodic memory for emotional information, limiting the generalization of the same neural path from animals to humans. Ventura-Bort et al. (2021) therefore investigated the role of the VN on the formation and consolidation of emotional episodic memories in humans using taVNS. In this study, participants underwent two encoding sessions in which unpleasant and neutral images were encoded while receiving taVNS or sham stimulation in a counterbalanced, within-subjects design. One week later, recognition memory was tested by also assessing the contribution of familiarity vs. recollection-based remembering (i.e., low vs. high confidence; Wixted and Stretch, 2004), with the latter representing a more elaborate mnemonic process that particularly reflects increased amygdala and hippocampal activity (, ).
Although no overall effects of VNS on memory performance were found (see also Ludwig et al., 2025), unpleasant images encoded under taVNS were more often retrieved with high confidence (Ventura-Bort et al., 2021), indicating a recollection-driven increase for emotional but not neutral images (see also Ludwig et al., 2025 for general memory improvements for unpleasant images encoded under taVNS). These findings were also accompanied by larger recollection-sensitive brain potentials (late ERP Old/New effect) during retrieval of emotional scenes encoded under taVNS, compared to sham stimulation (for a recent conceptual replication of the electrocortical findings using different stimulation protocols, see Ventura-Bort et al., 2025). Similar recollection-related results were also obtained in a behavioral study investigating the effects of taVNS on memory for emotional and neutral words (Giraudier et al., 2020). Although no overall effects of taVNS were found, participants receiving taVNS during the word encoding task showed a recollection-driven advantage (i.e., for words with the highest confidence) 1 day later (but see for no effects when taVNS was applied offline using a same day memory paradigm, Mertens et al., 2020). In contrast to Ventura-Bort et al. (2021), however, no emotion-specific memory enhancement was observed after taVNS (Giraudier et al., 2020), which may be partly explained by the use of the less arousing emotional material (words compared to high arousing pictures, c.f., Ventura-Bort et al. (2021)).
Altogether, these results suggest that stimulation of vagal afferents improves the formation of episodic, particularly recollection-based (i.e., hippocampal-mediated), memories, as indicated by behavioral and electrophysiological measures.
The role of the vagus nerve in associative memory
Importantly, it is not only vital for survival to remember distinct stimuli, but also to remember associations between them, ultimately allowing to anticipate upcoming events based on past experiences. In both animals and humans, such associative emotional memory is predominantly investigated by means of Pavlovian conditioning and extinction protocols. During conditioning, an inherently neutral conditioned stimulus (CS; e.g., a light in animal research; a geometrical figure in human research) repeatedly predicts the occurrence of an emotionally salient, i.e., unpleasant or pleasant, unconditioned stimulus (US; e.g., electric shock or food incentive) (Lonsdorf et al., 2017). As a result, the CS gains the capacity to elicit conditioned emotional responses (e.g., fear in case of a highly aversive US), reflecting a learned CS–US association (Lonsdorf et al., 2017). In contrast, during subsequent extinction protocols, the CS is no longer paired with any US (Lonsdorf et al., 2017). Thus, a novel association (CS-No US) is established, that inhibits the activation of an originally conditioned memory trace and thus reduces conditioned emotional responses (). Importantly, vagal projection targets (see Figure 1) play pivotal roles in both conditioning and extinction: Plasticity in the basolateral amygdala underlies initial associative learning (i.e., initial conditioning and extinction), while the medial prefrontal cortex is particularly involved in the consolidation and recall of extinction memory (Herry et al., 2008; Senn et al., 2014; Tovote et al., 2015; Szeska et al., 2022). In addition, noradrenaline heavily impacts on the plasticity in these areas, and consequently increased activity of the LC-NA system has found to promote associative memory processes (Uematsu et al., 2017; Giustino and Maren, 2018).
Accordingly, animal studies found promoted associative emotional memory by iVNS: Rats, that underwent an extinction protocol under iVNS, consistently show promoted extinction of previously conditioned fear–an effect, that maintains even for 10 days and may even reverse experimentally induced extinction impairments (Peña et al., 2013, 2014; ; Noble et al., 2017, 2019; Souza et al., 2019, 2021, 2022; see Table 1). Importantly, this extinction enhancement by iVNS is abolished if the LC is optogenetically silenced (), providing strong mechanistic evidence that respective memory improvements are dependent to vagal projections to the LC-NA system. Notably, the enhancing effects of iVNS are not limited to the extinction of fear, but also apply to the extinction of conditioned appetitive responses (e.g., cocaine-induced place preference) (, ). Animal research therefore strongly suggests, that the vagus nerve is involved in guiding the establishment of associative emotional memory, primarily through its projections to the LC-NA system.
Human research utilizing taVNS has largely translated these findings from the animal model, although results have been mixed (see e.g., and ; Szeska et al., 2020, 2021; see Table 1): Using a differential-cue Pavlovian fear conditioning paradigm, requiring discriminative learning between a threat and a safety cue, Burger and colleagues showed that taVNS accelerates the extinction of previously conditioned fear (, ). Notably, though, these extinction enhancements were limited to verbal report measures of fear (i.e., threat expectancy). Yet, in a simpler single-cue Pavlovian fear conditioning paradigm, which is more closely adapted to animal research and requires simpler associative learning (either threat learning or not in a between-group design), taVNS has found to accelerate the extinction of verbal report, behavioral and physiological components of the fear response (Szeska et al., 2020, 2021). Consistent with prolonged extinction enhancements observed in animals, such beneficial effect maintained for even 4 weeks. However, the extinction enhancements by taVNS may be limited to the learning of associations between distinct cues: In a differential-context Pavlovian fear conditioning protocol, requiring discriminative learning of a threat-signaling vs. safety-signaling environment in virtual reality, taVNS failed to promote the extinction of contextually-related conditioned responses (Genheimer et al., 2017).
As for episodic memory, the current body of evidence therefore also generally supports a pivotal role of the vagus nerve in the establishment of human associative emotional memory, although beneficial effects primarily unfold when simple cue-outcome relationships are to be learned.
A potential role of vagus nerve stimulation in the treatment of mental disorders
Based on the beneficial effects of non-invasive VNS on memory formation, this method was rendered a potential adjunct to the treatment of mental conditions, that are either marked by impairments in memory performance or where treatments are hinged upon successful learning of new information. In the following sections we will highlight such clinical areas, where taVNS may therefore be utilized to aid treatment strategies, including neurocognitive, anxiety and trauma-related disorders (see Figure 2).
FIGURE 2
Neurocognitive disorders
It is well established, that episodic and associative memory performance declines with increasing age (Shing et al., 2010; Greene and Naveh-Benjamin, 2020) and such memory decline has found to be partly grounded in LC integrity (; ) and overall neurodegenerative actions (Maass et al., 2018). Since VNS specifically targets the LC, but also increases overall cortical and hippocampal neuroplasticity (; Morrison et al., 2019; Keute and Gharabaghi, 2021), and invokes memory-enhancing effects (Ventura-Bort et al., 2021), it may be presumed that VNS might counter such deterioration in ageing individuals. In fact, taVNS has found to improve both episodic and associative memory in elderly people (Jacobs et al., 2015, see Table 1).
However, in some cases age-related impairments in memory performance are particularly pronounced: Mild cognitive impairment (MCI) describes such a condition of cognitive decline, which is has been conceptualized as an intermediate point between normal ageing and dementia (Simon et al., 2012). At this, MCI either includes memory impairments (amnestic subtypes) or not (non-amnestic subtypes) (). Importantly, amnestic MCI is highly present among elderly people, with studies reporting prevalence rates ranging from 0.5% up to 31.9% (median 4.9%) (Ward et al., 2012). To combat memory impairments in amnestic MCI, current treatments often build upon drugs like cholinesterase inhibitors (e.g., galantamine; Loy and Schneider, 2006) or cognitive interventions, such as visual imagery, chunking or cueing (Simon et al., 2012). However, given that MCI has found to be linked to reduced locus coeruleus integrity (Jacobs et al., 2021), such treatments could be complemented by LC-targeting taVNS, effectively utilizing its memory-enhancing effects: Indeed, preliminary data suggests that VNS triggered alterations in functional connectivity between memory-relevant brain regions (Murphy et al., 2023) and demonstrated to improve both the establishment of associative memory as well as immediate and delayed episodic memory recall in MCI patients (Wang et al., 2022; ).
Longitudinal studies indicated, that amnestic MCI is a critical risk factor for the development of Alzheimer’s disease (AD), as it progresses to AD at an average rate of 10%–17% per year (Ferman et al., 2013). This is not surprising, given that amnestic MCI and AD share common features of neurodegeneration and memory decline (Weller and Budson, 2018). According to the World Alzheimer Report 2018, it was estimated that about 50 million people worldwide suffer from AD, and it was projected that this prevalence will triple by the year of 2050 (Patterson, 2018). To combat the progredient memory loss in AD, effective treatments currently tap into similar mechanisms as therapeutic strategies for amnestic MCI: Drugs, such as cholinesterase inhibitor galantamine and NMDA-antagonist memantine, complemented by cognitive interventions (Loy and Schneider, 2006; Weller and Budson, 2018). Given the striking similarities between amnestic MCI and AD, it might be presumed that VNS could provide a valuable addition to this list. Indeed, first pilot studies suggest that taVNS might alleviate AD symptomatology (Sjogren et al., 2002; Merrill et al., 2006) and these effects are further tested in currently ongoing clinical trials (Vargas-Caballero et al., 2022).
Anxiety and trauma-related disorders
Besides neurocognitive disorders, memory processes also play a pivotal role in the etiology and treatment anxiety and trauma-related disorders–conditions, that share features of excessive fear-based symptoms elicited by distinct (trauma-related) fear cues (). Pavlovian fear conditioning is widely regarded as a model for the establishment of such excessive fear (). In contrast, fear extinction is considered to be an associative learning mechanism driving the success of exposure-based cognitive behavioral therapy–the current first-line treatment for anxiety and trauma-related disorders (; ). Such treatment involves the repeated exposure towards the patient’s individual fear cues, invoking extinction learning which ultimately results in a gradual inhibition of fear-based symptoms (). However, as indicated by basic research, extinction memory is rather fragile compared to the original fear memory trace (), and thus the organism remains prone to fear memory reactivation. Such proneness might be even more pronounced upon deficient extinction, which thus constitutes a risk factor for non-responding to treatment or relapses (Vervliet et al., 2013; Milad et al., 2014). Importantly, extinction deficits are prevalent in anxiety and trauma-related disorders, possibly contributing to high rates of non-responders (∼50%) and relapses (∼14%) in exposure-based treatments (Loerinc et al., 2015; Levy et al., 2021). Given the positive effects of both invasive and non-invasive VNS on the formation and recall of extinction memory in animals and humans (see above), VNS might constitute a valuable adjunct to overcome these deficits and boost the success of exposure-based therapeutic strategies.
In fact, first evidence on invasive VNS supports this view: In a recent study of Powers and colleagues (Powers et al., 2025), iVNS was combined with prolonged exposure therapy in treatment-resistant PTSD. By applying the invasive VNS during twelve treatment sessions, PTSD symptoms were indeed substantially alleviated–an effect, which persisted even 6 months after the cessation of therapy and ultimately resulted in a loss of PTSD diagnosis in all participants.
Non-invasive taVNS, which may be viewed as a more applicable alternative to iVNS due to not requiring surgery, results in similar effects: In a study of Szeska et al. (2025), spider phobic individuals underwent a standardized exposure in vivo towards a living tarantula, which was followed by a complementary taVNS-paired laboratory exposure in vitro, during which participants were presented with pictures of various spiders including the exposed specimen. Participants, that received active VNS during this complementary exposure indeed showed a stimulus-specific inhibition of fear responses, as indexed by attenuated fear tachycardia and corrugator activity towards pictures of the exposed tarantula–autonomic and behavioral components of fear, that serve as indirect read-outs of amygdala activity (Heller et al., 2014; Roelofs and Dayan, 2022). This effect became stronger with increasing stimulation duration, indicating a dose-dependency of stimulation effects. Importantly, fear attenuation even maintained after stimulation had ceased and participants were subjected to a second in vivo exposure: After receiving taVNS, participants were more likely to make physical contact with the phobic stimulus and touch the tarantula with bare hands, as opposed to participants that received a sham stimulation of the earlobe. Together, these results indicate that vagus nerve stimulation boosts a stimulus-specific reduction of fear responses in a dose-dependent manner, which culminates in promoted responding to exposure treatment.
In sum, current evidence therefore suggests that VNS might be a powerful adjunct for therapeutic regimen that build upon exposure effects (), including first-line treatments of anxiety, stressor-and trauma-related disorders, as well as obsessive-compulsive disorder.
Discussion
A prioritized storage of emotionally salient stimuli into long-term memory warrants that significant cues, people, places and events can be remembered in the future, thus acting as a prerequisite for behavioral adaptivity (). Animal research has long suggested the vagus nerve to be a central relay driving this effect, since adrenergic actions on this nerve in emotionally arousing situations elicit central noradrenergic release, which promotes plasticity in memory-relevant brain areas (McIntyre et al., 2012). The availability of electrical invasive and non-invasive vagus nerve stimulation (VNS) has recently opened up the possibility to test a comparable vagal route to memory in humans. In this review, we synthesized animal and human studies utilizing VNS, which altogether suggested that (1) the vagus nerve constitutes an evolutionarily preserved brain-body axis driving emotional memory formation and (2) VNS may consequently be used to promote emotional episodic and associative memory consolidation. Following up on the latter notion, we further discussed VNS as a tool to combat memory decline in neurocognitive disorders and as an adjuvant to facilitate learning processes underlying exposure-based treatment of anxiety and trauma-related disorders. In fact, preliminary evidence suggests that electrical VNS improves mnemonic performance in mild cognitive impairment and Alzheimer’s disease (Wang et al., 2022), just as it promotes responding to exposure-based treatment (Powers et al., 2025; Szeska et al., 2025), rendering electrical VNS as a promising adjunct to a variety of therapeutic strategies. Interestingly, this might also apply to non-electrical VNS: The afferent vagus nerve is a critical component of the microbiota-gut-brain axis and thus it may be possible to invoke VNS by manipulations of the microbiome to achieve similar beneficial effects (Kuijer and Steenbergen, 2023; Faraji et al., 2025).
Nevertheless, more research into the mechanisms of electrical VNS is necessary to fully exhaust its memory-enhancing potential and utilize this stimulation technique in clinical areas: Although there is abundant evidence that VNS increases noradrenergic transmission by projections to the locus coeruleus (Frangos et al., 2015; Yakunina et al., 2017; Ventura-Bort et al., 2018; Sclocco et al., 2019; ; Teckentrup et al., 2021; Giraudier et al., 2022), VNS also targets centers of other transmitter systems (Frangos et al., 2015) and thus modulates cholinergic (), dopaminergic (Manta et al., 2009; ), serotonergic (Manta et al., 2009, 2013) as well as glutamatergic and GABA-ergic neural transmission (). As each of these systems is involved in memory formation (Myhrer, 2003), the exact mechanism that underlies VNS-driven memory enhancement is yet to disentangle. Likewise, it needs to be determined under which conditions VNS yields the strongest memory-enhancing effects: Of the 40 articles included in our mini-review (see Table 1), only four have reported null-effects by VNS, with all using taVNS. Thus, we may preliminarily conclude that iVNS produces more consistent effects, possibly as it exhibits more direct action on the vagus. However, future studies need to additionally test the role of different stimulation parameters (frequency, intensity, duration; see ) in VNS effects: Indeed, it has been shown that adrenergic agents affect memory retention in an inverted-U-shaped function, that depends upon the arousal level of the organism, where exceeding levels of systemic adrenaline may even impair memory performance (Gold and Korol, 2012). As VNS is suggested to tap into similar mechanisms, it is tempting to speculate that its memory enhancing effects are similarly shaped, i.e., being strongest at intensities that – when acting upon the current arousal state – invoke moderate levels of adrenergic activation (for preliminary evidence, see Souza et al., 2021). However, besides the current arousal state, further individual characteristics may also shape VNS effects and need to be systematically investigated (e.g., age, genetic factors, baseline cognitive functions, but also baseline vagal tone). Furthermore, it needs to be tested how (1) acute vs. multiple stimulation, (2) online (during task) vs. offline stimulation (before and/or after task), (3) type of task (e.g., relying on HC function), and (4) immediate vs. delayed testing impact on the effects of VNS on learning and memory. This also applies to the affective valence of the encoded material: While our review showed that VNS enhances memory for unpleasant material, to best of our knowledge there is no study that investigated whether the same holds true for pleasant stimuli, despite (mnemonic) processing similarly taps into (nor-) adrenergic mechanisms (Sternberg et al., 1985; ). Hence, we hope that our mini-review strongly encourages specific experimental designs or meta-and mega-analytic approaches (see Giraudier et al., 2022) to answer these open research questions. While VNS is already an FDA-approved clinical treatment of epilepsy and drug-resistant major depressive disorder (and applied in further clinical trials focusing e.g., on Alzheimer’s disease, mild cognitive impairment, PTSD, alcohol use disorder or stroke rehabilitation; see (Herr et al., 2024)), addressing these gaps will help to integrate it even more effectively into therapeutic strategies and tailor this stimulation technique for specific patient populations.
Altogether, this mini-review revealed that the vagus nerve constitutes a major communication route between the body’s periphery and the brain, which is critically involved in the formation of emotional memories. Vagus nerve stimulation can therefore be considered as one of the most promising neuromodulation techniques to combat mental disorders, and its full potential at this is yet to unfold.
Statements
Author contributions
CS: Writing – original draft, Writing – review and editing. CV-B: Writing – review and editing. MG: Writing – review and editing. MW: Writing – review and editing.
Funding
The author(s) declare that financial support was received for the research and/or publication of this article. This research was supported by a grant from the German Research Foundation (DFG, WE 4801/6-1) to MW.
Conflict of interest
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Generative AI statement
The authors declare that no Generative AI was used in the creation of this manuscript.
Publisher’s note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
References
1
AbercrombieH. C.KalinN. H.ThurowM. E.RosenkranzM. A.DavidsonR. J. (2003). Cortisol variation in humans affects memory for emotionally laden and neutral information.Behav. Neurosci.117505–516. 10.1037/0735-7044.117.3.505
2
AdolphsR.CahillL.SchulR.BabinskyR. (1997). Impaired declarative memory for emotional material following bilateral amygdala damage in humans.Learn. Mem.4291–300. 10.1101/lm.4.3.291
3
Alvarez-DieppaA. C.GriffinK.CavalierS.McintyreC. K. (2016). Vagus nerve stimulation enhances extinction of conditioned fear in rats and modulates arc protein, CaMKII, and GluN2B-Containing NMDA receptors in the basolateral amygdala.Neural Plast.2016:4273280. 10.1155/2016/4273280
4
American Psychiatric Association (2013). Diagnostic and statistical manual of mental disorders.Washington, D.C: American Psychiatric Association. 10.1176/appi.books.9780890425596
5
Ben-MenachemE.HambergerA.HednerT.HammondE. J.UthmanB. M.SlaterJ.et al (1995). Effects of vagus nerve stimulation on amino acids and other metabolites in the CSF of patients with partial seizures.Epilepsy Res.20221–227. 10.1016/0920-1211(94)00083-9
6
BerthoudH. R.NeuhuberW. L. (2000). Functional and chemical anatomy of the afferent vagal system.Autonom. Neurosci. Basic Clin.851–17. 10.1016/S1566-0702(00)00215-0
7
BiggioF.GoriniG.UtzeriC.OllaP.MarrosuF.MocchettiI.et al (2009). Chronic vagus nerve stimulation induces neuronal plasticity in the rat hippocampus.Int. J. Neuropsychopharmacol.121209–1221. 10.1017/S1461145709000200
8
BorgmannD.RigouxL.KuzmanovicB.Edwin ThanarajahS.MünteT. F.FenselauH.et al (2021). Technical note: Modulation of fMRI brainstem responses by transcutaneous vagus nerve stimulation.Neuroimage244:118566. 10.1016/j.neuroimage.2021.118566
9
BorrellJ.De KloetE. R.VersteegD. H. G.BohusB. (1983). Inhibitory avoidance deficit following short-term adrenalectomy in the rat: The role of adrenal catecholamines.Behav. Neural Biol.39241–258. 10.1016/S0163-1047(83)90910-X
10
BowlesS.HickmanJ.PengX.WilliamsonW. R.HuangR.WashingtonK.et al (2022). Vagus nerve stimulation drives selective circuit modulation through cholinergic reinforcement.Neuron1102867–2885.e7. 10.1016/j.neuron.2022.06.017.
11
BradfieldN. I. (2023). Mild cognitive impairment: Diagnosis and subtypes.Clin. EEG Neurosci.544–11. 10.1177/15500594211042708
12
BradleyM. M.CodispotiM.CuthbertB. N.LangP. J. (2001a). Emotion and motivation I: Defensive and appetitive reactions in picture processing.Emotion1276–298. 10.1037/1528-3542.1.3.276
13
BradleyM. M.CodispotiM.CuthbertB. N.LangP. J. (2001b). Emotion and motivation II: Sex differences in picture processing.Emotion1300–319. 10.1037/1528-3542.1.3.300
14
BradleyM. M.GreenwaldM. K.PetryM. C.LangP. J. (1992). Remembering pictures: Pleasure and arousal in memory.J. Exp. Psychol. Learn. Mem. Cogn.18379–390. 10.1037/0278-7393.18.2.379
15
BrougherJ.AzizU.AdariN.ChaturvediM.JulesA.ShahI.et al (2021). Self-Administration of right vagus nerve stimulation activates midbrain dopaminergic nuclei.Front. Neurosci.15:782786. 10.3389/fnins.2021.782786
16
BurgerA. M.Van DiestI.van der DoesW.HysajM.ThayerJ. F.BrosschotJ. F.et al (2018). Transcutaneous vagus nerve stimulation and extinction of prepared fear: A conceptual non-replication.Sci. Rep.8:11471. 10.1038/s41598-018-29561-w
17
BurgerA. M.VerkuilB.FenlonH.ThijsL.CoolsL.MillerH. C.et al (2017). Mixed evidence for the potential of non-invasive transcutaneous vagal nerve stimulation to improve the extinction and retention of fear.Behav. Res. Ther.9764–74. 10.1016/j.brat.2017.07.005
18
BurgerA. M.VerkuilB.Van DiestI.Van der DoesW.ThayerJ. F.BrosschotJ. F. (2016). The effects of transcutaneous vagus nerve stimulation on conditioned fear extinction in humans.Neurobiol. Learn. Mem.13249–56. 10.1016/j.nlm.2016.05.007
19
CahillL.AlkireM. T. (2003). Epinephrine enhancement of human memory consolidation: Interaction with arousal at encoding.Neurobiol. Learn. Mem.79194–198. 10.1016/S1074-7427(02)00036-9
20
Calderon-WilliamsD. R.de SouzaR. R.TsengC. T.AbdiH.Sandoval-FloresA.PloskiJ. E.et al (2024). Optogenetic inhibition of the locus coeruleus blocks vagus nerve stimulation-induced enhancement of extinction of conditioned fear in rats.Learn. Mem.31:a053958. 10.1101/lm.053958.124
21
CanliT.ZhaoZ.BrewerJ.GabrieliJ. D.CahillL. (2000). Event-related activation in the human amygdala associates with later memory for individual emotional experience.J. Neurosci.20:RC99. 10.1523/jneurosci.20-19-j0004.2000
22
CarpenterJ. K.AndrewsL. A.WitcraftS. M.PowersM. B.SmitsJ. A. J.HofmannS. G. (2018). Cognitive behavioral therapy for anxiety and related disorders: A meta-analysis of randomized placebo-controlled trials.Dep. Anxiety35502–514. 10.1002/da.22728
23
ChildsJ. E.DeLeonJ.NickelE.KroenerS. (2017). Vagus nerve stimulation reduces cocaine seeking and alters plasticity in the extinction network.Learn. Mem.2435–42. 10.1101/lm.043539.116
24
ChildsJ. E.KimS.DriskillC. M.HsiuE.KroenerS. (2019). Vagus nerve stimulation during extinction learning reduces conditioned place preference and context-induced reinstatement of cocaine seeking.Brain Stimul.121448–1455. 10.1016/j.brs.2019.07.001
25
ClarkK. B.KrahlS. E.SmithD. C.JensenR. A. (1995). Post-training unilateral vagal stimulation enhances retention performance in the rat.Neurobiol. Learn. Mem.63213–216. 10.1006/nlme.1995.1024
26
ClarkK. B.NaritokuD. K.SmithD. C.BrowningR. A.JensenR. A. (1999). Enhanced recognition memory following vagus nerve stimulation in human subjects.Nat. Neurosci.294–98. 10.1038/4600
27
ClarkK. B.SmithD. C.HassertD. L.BrowningR. A.NaritokuD. K.JensenR. A. (1998). Posttraining electrical stimulation of vagal afferents with concomitant vagal efferent inactivation enhances memory storage processes in the rat.Neurobiol. Learn. Mem.70364–373. 10.1006/nlme.1998.3863
28
CodispotiM.GerraG.MontebarocciO.ZaimovicA.RaggiM. A.BaldaroB. (2003). Emotional perception and neuroendocrine changes.Psychophysiology40863–868. 10.1111/1469-8986.00104
29
CooperC. M.FarrandA. Q.AndresenM. C.BeaumontE. (2021). Vagus nerve stimulation activates nucleus of solitary tract neurons via supramedullary pathways.J. Physiol.5995261–5279. 10.1113/JP282064
30
CouplandR. E.ParkerT. L.KesseW. K.MohamedA. A. (1989). The innervation of the adrenal gland. III. Vagal innervation.J. Anat.163173–181. 10.1002/cne.900640307
31
CraskeM. G.HermansD.VansteenwegenD. (2006). Fear and learning: From basic processes to clinical implications.Washington, D.C: American Psychological Association.
32
CraskeM. G.TreanorM.ConwayC. C.ZbozinekT.VervlietB. (2014). Maximizing exposure therapy: An inhibitory learning approach.Behav. Res. Ther.5810–23. 10.1016/j.brat.2014.04.006
33
D’AgostiniM.BurgerA. M.FranssenM.PerkovicA.ClaesS.von LeupoldtA.et al (2023). Short bursts of transcutaneous auricular vagus nerve stimulation enhance evoked pupil dilation as a function of stimulation parameters.Cortex159233–253. 10.1016/j.cortex.2022.11.012
34
D’AgostiniM.Vanden BosscheL.BurgerA. M.Van DiestI. (2025). Transcutaneous auricular vagus nerve stimulation does not accelerate fear extinction: A randomized, sham-controlled study.Psychophysiology62:e14754. 10.1111/psyp.14754
35
DahlM. J.KuleszaA.Werkle-BergnerM.MatherM. (2023). Declining locus coeruleus–dopaminergic and noradrenergic modulation of long-term memory in aging and Alzheimer’s disease. Neurosci. Biobehav. Rev.153:105358. 10.1016/j.neubiorev.2023.105358
36
DahlM. J.MatherM.DüzelS.BodammerN. C.LindenbergerU.KühnS.et al (2019). Rostral locus coeruleus integrity is associated with better memory performance in older adults.Nat. Hum. Behav.31203–1214. 10.1038/s41562-019-0715-2
37
DolanR. J. (2002). Neuroscience and psychology: Emotion, cognition, and behavior.Science2981191–1194. 10.1126/science.1076358
38
DolcosF.KatsumiY.BogdanP. C.ShenC.JunS.BuettiS.et al (2020). The impact of focused attention on subsequent emotional recollection: A functional MRI investigation.Neuropsychologia138:107338. 10.1016/j.neuropsychologia.2020.107338
39
DolcosF.LaBarK. S.CabezaR. (2004). Dissociable effects of arousal and valence on prefrontal activity indexing emotional evaluation and subsequent memory: An event-related fMRI study.Neuroimage2364–74. 10.1016/j.neuroimage.2004.05.015
40
DolcosF.LaBarK. S.CabezaR. (2005). Remembering one year later: Role of the amygdala and the medial temporal lobe memory system in retrieving emotional memories.Proc. Natl. Acad. Sci. U. S. A.1022626–2631. 10.1073/pnas.0409848102
41
DolphinH.DyerA. H.DukelowT.ComminsS.FinucaneC.KennellyS. (2023). Neuromodulation for mild cognitive impairment: Improvements in spatial navigation and associative memory with acute transcutaneous vagus nerve stimulation: VINCI-AD.Alzheimer’s Dement.19:83030. 10.1002/alz.083030
42
DunsmoorJ. E.KroesM. C. (2019). Episodic memory and Pavlovian conditioning: Ships passing in the night.Curr. Opin. Behav. Sci.2632–39. 10.1016/j.cobeha.2018.09.019
43
DunsmoorJ. E.MurtyV. P.DavachiL.PhelpsE. A. (2015a). Emotional learning selectively and retroactively strengthens memories for related events.Nature520345–348. 10.1038/nature14106
44
DunsmoorJ. E.NivY.DawN.PhelpsE. A. (2015b). Rethinking Extinction.Neuron8847–63. 10.1016/j.neuron.2015.09.028
45
EasterbrookJ. A. (1959). The effect of emotion on cue utilization and the organization of behavior.Psychol. Rev.66183–201. 10.1037/h0047707
46
FarajiN.PayamiB.EbadpourN.GorjiA. (2025). Vagus nerve stimulation and gut microbiota interactions: A novel therapeutic avenue for neuropsychiatric disorders.Neurosci. Biobehav. Rev.169:105990. 10.1016/j.neubiorev.2024.105990
47
FermanT. J.SmithG. E.KantarciK.BoeveB. F.PankratzV. S.DicksonD. W.et al (2013). Nonamnestic mild cognitive impairment progresses to dementia with Lewy bodies.Neurology812032–2038. 10.1212/01.wnl.0000436942.55281.47
48
FoleyJ. O.DuBoisF. S. (1937). Quantitative studies of the vagus nerve in the cat. I. The ratio of sensory to motor fibers.J. Comp. Neurol.6749–67. 10.1002/cne.900670104
49
FrangosE.EllrichJ.KomisarukB. R. (2015). Non-invasive access to the vagus nerve central projections via electrical stimulation of the external ear: FMRI evidence in humans.Brain Stimul.8624–636. 10.1016/j.brs.2014.11.018
50
GenheimerH.AndreattaM.AsanE.PauliP. (2017). Reinstatement of contextual conditioned anxiety in virtual reality and the effects of transcutaneous vagus nerve stimulation in humans.Sci. Rep.7:17886. 10.1038/s41598-017-18183-3
51
GhacibehG. A.ShenkerJ. I.ShenalB.UthmanB. M.HeilmanK. M. (2006). Effect of vagus nerve stimulation on creativity and cognitive flexibility.Epilepsy Behav.8720–725. 10.1016/j.yebeh.2006.03.008
52
GiraudierM.Ventura-BortC.BurgerA. M.ClaesN.D’AgostiniM.FischerR.et al (2022). Evidence for a modulating effect of transcutaneous auricular vagus nerve stimulation (taVNS) on salivary alpha-amylase as indirect noradrenergic marker: A pooled mega-analysis.Brain Stimul.151378–1388. 10.1016/j.brs.2022.09.009
53
GiraudierM.Ventura-BortC.SzeskaC.WeymarM. (2025). A pooled analysis of the side effects of non-invasive transcutaneous auricular vagus nerve stimulation (taVNS).Front. Hum. Neurosci.19:1539416. 10.3389/fnhum.2025.1539416
54
GiraudierM.Ventura-BortC.WeymarM. (2020). Transcutaneous Vagus Nerve Stimulation (tVNS) improves high-confidence recognition memory but not emotional word processing.Front. Psychol.11:1276. 10.3389/fpsyg.2020.01276
55
GiustinoT. F.MarenS. (2018). Noradrenergic modulation of fear conditioning and extinction.Front. Behav. Neurosci.12:43. 10.3389/fnbeh.2018.00043
56
GoldP. E.KorolD. L. (2012). Making memories matter.Front. Integr. Neurosci.6:116. 10.3389/fnint.2012.00116
57
GreeneN. R.Naveh-BenjaminM. (2020). A Specificity principle of memory: Evidence from aging and associative memory.Psychol. Sci.31316–331. 10.1177/0956797620901760
58
HamannS. B.CahillL.SquireL. R. (1997). Emotional perception and memory in amnesia.Neuropsychology11104–113. 10.1037/0894-4105.11.1.104
59
HassertD. L.MiyashitaT.WilliamsC. L. (2004). The effects of peripheral vagal nerve stimulation at a memory-modulating intensity on norepinephrine output in the basolateral amygdala.Behav. Neurosci.11879–88. 10.1037/0735-7044.118.1.79
60
HellerA. S.LapateR. C.MayerK. E.DavidsonR. J. (2014). The face of negative affect: Trial-by-Trial corrugator responses to negative pictures are positively associated with amygdala and negatively associated with ventromedial prefrontal cortex activity.J. Cogn. Neurosci.262102–2110. 10.1162/jocn_a_00622
61
HerrT.KlegerP.StraussS.SzeskaC.KhalilN.BadranB. W.et al (2024). Effect of non-invasive transcutaneous auricular vagus nerve stimulation on cerebral motor excitability—study protocol for a randomized, sham controlled trial.Front. Neurol.14:1341898. 10.3389/fneur.2023.1341898
62
HerryC.CiocchiS.SennV.DemmouL.MüllerC.LüthiA. (2008). Switching on and off fear by distinct neuronal circuits.Nature454600–606. 10.1038/nature07166
63
HulseyD. R.RileyJ. R.LoerwaldK. W.RennakerR. L.KilgardM. P.HaysS. A. (2017). Parametric characterization of neural activity in the locus coeruleus in response to vagus nerve stimulation.Exp. Neurol.28921–30. 10.1016/j.expneurol.2016.12.005
64
JacobsH. I. L.BeckerJ. A.KwongK.Engels-DomínguezN.ProkopiouP. C.PappK. V.et al (2021). In vivo and neuropathology data support locus coeruleus integrity as indicator of Alzheimer’s disease pathology and cognitive decline.Sci. Transl. Med.13:eabj2511. 10.1126/scitranslmed.abj2511
65
JacobsH. I. L. L.RiphagenJ. M.RazatC. M.WieseS.SackA. T. (2015). Transcutaneous vagus nerve stimulation boosts associative memory in older individuals.Neurobiol. Aging361860–1867. 10.1016/j.neurobiolaging.2015.02.023
66
JamesW. (1890). The principles of psychology.New York, NY: Henry Holt and Co, 10.1037/10538-000
67
KensingerE. A. (2004). Remembering emotional experiences: The contribution of valence and arousal.Rev. Neurosci.15241–251. 10.1515/REVNEURO.2004.15.4.241
68
KeuteM.GharabaghiA. (2021). Brain plasticity and vagus nerve stimulation.Auton. Neurosci.236:102876. 10.1016/j.autneu.2021.102876
69
KuijerE. J.SteenbergenL. (2023). The microbiota-gut-brain axis in hippocampus-dependent learning and memory: Current state and future challenges.Neurosci. Biobehav. Rev.152:105296. 10.1016/j.neubiorev.2023.105296
70
LaBarK. S.CabezaR. (2006). Cognitive neuroscience of emotional memory.Nat. Rev. Neurosci.754–64. 10.1038/nrn1825
71
LevyH. C.O’BryanE. M.TolinD. F. (2021). A meta-analysis of relapse rates in cognitive-behavioral therapy for anxiety disorders.J. Anxiety Disord.81:102407. 10.1016/j.janxdis.2021.102407
72
LiangK. C.ChenL. L.HuangT. E. (1995). The role of amygdala norepinephrine in memory formation: Involvement in the memory enhancing effect of peripheral epinephrine.Chin. J. Physiol.3881–91. 10.1016/j.brs.2012.09.010
73
LoerincA. G.MeuretA. E.TwohigM. P.RosenfieldD.BluettE. J.CraskeM. G. (2015). Response rates for CBT for anxiety disorders: Need for standardized criteria.Clin. Psychol. Rev.4272–82. 10.1016/j.cpr.2015.08.004
74
LonsdorfT. B.MenzM. M.AndreattaM.FullanaM. A.GolkarA.HaakerJ.et al (2017). Don’t fear ‘fear conditioning’: Methodological considerations for the design and analysis of studies on human fear acquisition, extinction, and return of fear.Neurosci. Biobehav. Rev.77247–285. 10.1016/j.neubiorev.2017.02.026
75
LoyC.SchneiderL. (2006). Galantamine for Alzheimer’s disease and mild cognitive impairment.Cochrane Database Syst. Rev.2009116–117. 10.1002/14651858.CD001747.pub3
76
LudwigM.BettsM. J.HämmererD. (2025). Stimulate to remember? the effects of short burst of transcutaneous vagus nerve stimulation (taVNS) on memory performance and pupil dilation.Psychophysiology62:e14753. 10.1111/psyp.14753
77
MaassA.LockhartS. N.HarrisonT. M.BellR. K.MellingerT.SwinnertonK.et al (2018). Entorhinal tau pathology, episodic memory decline, and neurodegeneration in aging.J. Neurosci.38530–543. 10.1523/JNEUROSCI.2028-17.2017
78
MantaS.DongJ.DebonnelG.BlierP. (2009). Enhancement of the function of rat serotonin and norepinephrine neurons by sustained vagus nerve stimulation.J. Psychiatry Neurosci.34272–280.
79
MantaS.El MansariM.DebonnelG.BlierP. (2013). Electrophysiological and neurochemical effects of long-term vagus nerve stimulation on the rat monoaminergic systems.Int. J. Neuropsychopharmacol.16459–470. 10.1017/S1461145712000387
80
MatherM.ClewettD.SakakiM.HarleyC. W. (2016). Norepinephrine ignites local hotspots of neuronal excitation: How arousal amplifies selectivity in perception and memory.Behav. Brain Sci.39:e200. 10.1017/S0140525X15000667
81
McGaughJ. L. (2018). Emotional arousal regulation of memory consolidation.Curr. Opin. Behav. Sci.1955–60. 10.1016/j.cobeha.2017.10.003
82
McIntyreC. K.McGaughJ. L.WilliamsC. L. (2012). Interacting brain systems modulate memory consolidation.Neurosci. Biobehav. Rev.361750–1762. 10.1016/j.neubiorev.2011.11.001
83
MerrillC. A.JonssonM. A. G.MinthonL.EjnellH.SilanderH. C.BlennowK.et al (2006). Vagus nerve stimulation in patients with Alzheimer’s disease.J. Clin. Psychiatry671171–1178. 10.4088/JCP.v67n0801
84
MertensA.GadeyneS.LescrauwaetE.CarretteE.MeursA.De HerdtV.et al (2022). The potential of invasive and non-invasive vagus nerve stimulation to improve verbal memory performance in epilepsy patients.Sci. Rep.12:1984. 10.1038/s41598-022-05842-3
85
MertensA.NaertL.MiattonM.PoppaT.CarretteE.GadeyneS.et al (2020). Transcutaneous vagus nerve stimulation does not affect verbal memory performance in healthy volunteers.Front. Psychol.11:551. 10.3389/fpsyg.2020.00551
86
MiladM. R.RosenbaumB. L.SimonN. M. (2014). Neuroscience of fear extinction: Implications for assessment and treatment of fear-based and anxiety related disorders.Behav. Res. Ther.6217–23. 10.1016/j.brat.2014.08.006
87
MiyashitaT.WilliamsC. L. (2004). Peripheral arousal-related hormones modulate norepinephrine release in the hippocampus via influences on brainstem nuclei.Behav. Brain Res.15387–95. 10.1016/j.bbr.2003.11.005
88
MiyashitaT.WilliamsC. L. (2006). Epinephrine administration increases neural impulses propagated along the vagus nerve: Role of peripheral β-adrenergic receptors.Neurobiol. Learn. Mem.85116–124. 10.1016/j.nlm.2005.08.013
89
MorrisonR. A.HulseyD. R.AdcockK. S.RennakerR. L.KilgardM. P.HaysS. A. (2019). Vagus nerve stimulation intensity influences motor cortex plasticity.Brain Stimul.12256–262. 10.1016/j.brs.2018.10.017
90
MurphyA. J.O’NealA. G.CohenR. A.LambD. G.PorgesE. C.BottariS. A.et al (2023). The effects of transcutaneous vagus nerve stimulation on functional connectivity within semantic and hippocampal networks in mild cognitive impairment.Neurotherapeutics20419–430. 10.1007/s13311-022-01318-4
91
MyhrerT. (2003). Neurotransmitter systems involved in learning and memory in the rat: A meta-analysis based on studies of four behavioral tasks.Brain Res. Rev.41268–287. 10.1016/S0165-0173(02)00268-0
92
NaterU. M.MoorC.OkereU.StallkampR.MartinM.EhlertU.et al (2007). Performance on a declarative memory task is better in high than low cortisol responders to psychosocial stress.Psychoneuroendocrinology32758–763. 10.1016/j.psyneuen.2007.05.006
93
NielsonK. A.RadtkeR. C.JensenR. A. (1996). Arousal-induced modulation of memory storage processes in humans.Neurobiol. Learn. Mem.66133–142. 10.1006/nlme.1996.0054
94
NiijimaA. (1992). Electrophysiological study on the vagal innervation of the adrenal gland in the rat.J. Auton. Nerv. Syst.4187–92.
95
NobleL. J.GonzalezI. J.MeruvaV. B.CallahanK. A.BelfortB. D.RamanathanK. R.et al (2017). Effects of vagus nerve stimulation on extinction of conditioned fear and post-traumatic stress disorder symptoms in rats.Transl. Psychiatry7:e1217. 10.1038/tp.2017.191
96
NobleL. J.MeruvaV. B.HaysS. A.RennakerR. L.KilgardM. P.McIntyreC. K. (2019). Vagus nerve stimulation promotes generalization of conditioned fear extinction and reduces anxiety in rats.Brain Stimul.129–18.
97
OlsenL. K.MooreR. J.BechmannN. A.EthridgeV. T.GargasN. M.CunninghamS. D.et al (2022). Vagus nerve stimulation-induced cognitive enhancement: Hippocampal neuroplasticity in healthy male rats.Brain Stimul.151101–1110. 10.1016/j.brs.2022.08.001
98
OlsenL. K.SolisE.McIntireL. K.Hatcher-SolisC. N. (2023). Vagus nerve stimulation: Mechanisms and factors involved in memory enhancement.Front. Hum. Neurosci.17:1152064. 10.3389/fnhum.2023.1152064
99
PatilA.MurtyV. P.DunsmoorJ. E.PhelpsE. A.DavachiL. (2017). Reward retroactively enhances memory consolidation for related items.Learn. Mem.2465–69. 10.1101/lm.042978.116
100
PattersonC. (2018). World Alzheimer report 2018 - The state of the art of dementia research: New frontiers.London: An Analysis of Prevalence, Incidence, Cost and Trends.
101
PeñaD. F.ChildsJ. E.WillettS.VitalA.McIntyreC. K.KroenerS. (2014). Vagus nerve stimulation enhances extinction of conditioned fear and modulates plasticity in the pathway from the ventromedial prefrontal cortex to the amygdala.Front. Behav. Neurosci.8:327. 10.3389/fnbeh.2014.00327
102
PeñaD. F.EngineerN. D.McIntyreC. K. (2013). Rapid remission of conditioned fear expression with extinction training paired with vagus nerve stimulation.Biol. Psychiatry731071–1077. 10.1016/j.biopsych.2012.10.021
103
PeukerE. T.FillerT. J. (2002). The nerve supply of the human auricle.Clin. Anat.1535–37. 10.1002/ca.1089
104
PhelpsE. A.LabarK. S.AndersonA. K.O’connorK. J.FulbrightR. K.SpencerD. D. (1998). specifying the contributions of the human amygdala to emotional memory: A case study.Neurocase4527–540. 10.1080/13554799808410645
105
PowersM. B.HaysS. A.RosenfieldD.PorterA. L.GallawayH.ChauvetteG.et al (2025). Vagus nerve stimulation therapy for treatment-resistant PTSD.Brain Stimul.18665–675. 10.1016/j.brs.2025.03.007
106
RickardN. S.WongW. W.VelikL. (2012). Relaxing music counters heightened consolidation of emotional memory.Neurobiol. Learn. Mem.97220–228. 10.1016/j.nlm.2011.12.005
107
RitcheyM.DolcosF.CabezaR. (2008). Role of amygdala connectivity in the persistence of emotional memories over time: An event-related fMRI investigation.Cereb. Cortex182494–2504. 10.1093/cercor/bhm262
108
RoelofsK.DayanP. (2022). Freezing revisited: Coordinated autonomic and central optimization of threat coping.Nat. Rev. Neurosci.23568–580. 10.1038/s41583-022-00608-2
109
RoozendaalB.McEwenB. S.ChattarjiS. (2009). Stress, memory and the amygdala.Nat. Rev. Neurosci.10423–433. 10.1038/nrn2651
110
RouhaniN.NivY.FrankM. J.SchwabeL. (2023). Multiple routes to enhanced memory for emotionally relevant events.Trends Cogn. Sci.27867–882. 10.1016/j.tics.2023.06.006
111
SandersT. H.WeissJ.HogewoodL.ChenL.PatonC.McMahanR. L.et al (2019). Cognition-Enhancing vagus nerve stimulation alters the epigenetic landscape.J. Neurosci.392407–2418. 10.1523/JNEUROSCI.2407-18.2019
112
SchwabeL.BohringerA.ChatterjeeM.SchachingerH. (2008). Effects of pre-learning stress on memory for neutral, positive and negative words: Different roles of cortisol and autonomic arousal.Neurobiol. Learn. Mem.9044–53. 10.1016/j.nlm.2008.02.002
113
ScloccoR.GarciaR. G.KettnerN. W.IsenburgK.FisherH. P.HubbardC. S.et al (2019). The influence of respiration on brainstem and cardiovagal response to auricular vagus nerve stimulation: A multimodal ultrahigh-field (7T) fMRI study.Brain Stimul.12911–921. 10.1016/j.brs.2019.02.003
114
SegalS. K.CahillL. (2009). Endogenous noradrenergic activation and memory for emotional material in men and women.Psychoneuroendocrinology341263–1271. 10.1016/j.psyneuen.2009.04.020
115
SennV.WolffS. B. E.HerryC.GrenierF.EhrlichI.GründemannJ.et al (2014). Long-range connectivity defines behavioral specificity of amygdala neurons.Neuron81428–437. 10.1016/j.neuron.2013.11.006
116
ShingY. L.Werkle-BergnerM.BrehmerY.MüllerV.LiS. C.LindenbergerU. (2010). Episodic memory across the lifespan: The contributions of associative and strategic components.Neurosci. Biobehav. Rev.341080–1091. 10.1016/j.neubiorev.2009.11.002
117
SimonS. S.YokomizoJ. E.BottinoC. M. C. (2012). Cognitive intervention in amnestic mild cognitive impairment: A systematic review.Neurosci. Biobehav. Rev.361163–1178. 10.1016/j.neubiorev.2012.01.007
118
SjogrenM. J. C.HellstromP. T. O.JonssonM. A. G.RunnerstamM.C-Son SilanderH.Ben-MenachemE.et al (2002). Cognition-Enhancing effect of vagus nerve stimulation in patients with Alzheimer’s disease.J. Clin. Psychiatry63972–980. 10.4088/JCP.v63n1103
119
SouzaR. R.PowersM. B.RennakerR. L.McIntyreC. K.HaysS. A.KilgardM. P. (2022). Timing of vagus nerve stimulation during fear extinction determines efficacy in a rat model of PTSD.Sci. Rep.12:16526. 10.1038/s41598-022-20301-9
120
SouzaR. R.RobertsonN. M.McIntyreC. K.RennakerR. L.HaysS. A.KilgardM. P. (2021). Vagus nerve stimulation enhances fear extinction as an inverted-U function of stimulation intensity.Exp. Neurol.341:113718. 10.1016/j.expneurol.2021.113718
121
SouzaR. R.RobertsonN. M.PruittD. T.GonzalesP. A.HaysS. A.RennakerR. L.et al (2019). Vagus nerve stimulation reverses the extinction impairments in a model of PTSD with prolonged and repeated trauma.Stress22509–520. 10.1080/10253890.2019.1602604
122
SternbergD. B.IsaacsK. R.GoldP. E.McGaughJ. L. (1985). Epinephrine facilitation of appetitive learning: Attenuation with adrenergic receptor antagonists.Behav. Neural Biol.44447–453. 10.1016/S0163-1047(85)90856-8
123
SzeskaC.KlepzigK.HammA. O.WeymarM. (2025). Ready for translation: Non-invasive auricular vagus nerve stimulation inhibits psychophysiological indices of stimulus-specific fear and facilitates responding to repeated exposure in phobic individuals.Transl. Psychiatry15:135. 10.1038/s41398-025-03352-0
124
SzeskaC.PünjerH.RiemannS.MeinzerM.HammA. O. (2022). Stimulation of the ventromedial prefrontal cortex blocks the return of subcortically mediated fear responses.Transl. Psychiatry12:394. 10.1038/s41398-022-02174-8
125
SzeskaC.RichterJ.WendtJ.WeymarM.HammA. O. (2020). Promoting long-term inhibition of human fear responses by non-invasive transcutaneous vagus nerve stimulation during extinction training.Sci. Rep.10:1529. 10.1038/s41598-020-58412-w
126
SzeskaC.RichterJ.WendtJ.WeymarM.HammA. O. (2021). Attentive immobility in the face of inevitable distal threat—Startle potentiation and fear bradycardia as an index of emotion and attention.Psychophysiology58:e13812. 10.1111/psyp.13812
127
TeckentrupV.KrylovaM.JamalabadiH.NeubertS.NeuserM. P.HartigR.et al (2021). Brain signaling dynamics after vagus nerve stimulation.Neuroimage245:118679. 10.1016/j.neuroimage.2021.118679
128
TovoteP.FadokJ. P.LüthiA. (2015). Neuronal circuits for fear and anxiety.Nat. Rev. Neurosci.16317–331. 10.1038/nrn3945
129
UematsuA.TanB. Z.YcuE. A.CuevasJ. S.KoivumaaJ.JunyentF.et al (2017). Modular organization of the brainstem noradrenaline system coordinates opposing learning states.Nat. Neurosci.201602–1611. 10.1038/nn.4642
130
Van StegerenA.RohlederN.EveraerdW.WolfO. T. (2006). Salivary alpha amylase as marker for adrenergic activity during stress: Effect of betablockade.Psychoneuroendocrinology31137–141. 10.1016/j.psyneuen.2005.05.012
131
Van StegerenA. H.EveraerdW.CahillL.McGaughJ. L.GoorenL. J. G. (1998). Memory for emotional events: Differential effects of centrally versus peripherally acting β-blocking agents.Psychopharmacology138305–310. 10.1007/s002130050675
132
van StegerenA. H.WolfO. T.EveraerdW.ScheltensP.BarkhofF.RomboutsS. A. R. B. (2007). Endogenous cortisol level interacts with noradrenergic activation in the human amygdala.Neurobiol. Learn. Mem.8757–66. 10.1016/j.nlm.2006.05.008
133
Vargas-CaballeroM.WarmingH.WalkerR.HolmesC.CruickshankG.PatelB. (2022). Vagus nerve stimulation as a potential therapy in early alzheimer’s disease: A review.Front. Hum. Neurosci.16:866434. 10.3389/fnhum.2022.866434
134
Ventura-BortC.GiraudierM.WeymarM. (2025). Transcutaneous auricular vagus nerve stimulation enhances emotional processing and long-term recognition memory: Electrophysiological evidence across two studies.Psychophysiology62:e70034. 10.1111/psyp.70034
135
Ventura-BortC.WirknerJ.GenheimerH.WendtJ.HammA. O.WeymarM. (2018). Effects of Transcutaneous Vagus Nerve Stimulation (tVNS) on the P300 and alpha-amylase level: A pilot study.Front. Hum. Neurosci.12:202. 10.3389/fnhum.2018.00202
136
Ventura-BortC.WirknerJ.WendtJ.HammA. O.WeymarM. (2021). Establishment of emotional memories is mediated by vagal nerve activation: Evidence from noninvasive tavns.J. Neurosci.417636–7648. 10.1523/JNEUROSCI.2329-20.2021
137
VervlietB.CraskeM. G.HermansD. (2013). Fear extinction and relapse: State of the art.Annu. Rev. Clin. Psychol.9215–248. 10.1146/annurev-clinpsy-050212-185542
138
WangB.BukuanS. (2015). Timing matters: Negative emotion elicited 5min but not 30min or 45min after learning enhances consolidation of internal-monitoring source memory.Acta Psychol.15756–64. 10.1016/j.actpsy.2015.02.006
139
WangL.ZhangJ.GuoC.HeJ.ZhangS.WangY.et al (2022). The efficacy and safety of transcutaneous auricular vagus nerve stimulation in patients with mild cognitive impairment: A double blinded randomized clinical trial.Brain Stimul.151405–1414. 10.1016/j.brs.2022.09.003
140
WardA.ArrighiH. M.MichelsS.CedarbaumJ. M. (2012). Mild cognitive impairment: Disparity of incidence and prevalence estimates.Alzheimer’s Dement.814–21. 10.1016/j.jalz.2011.01.002
141
Weil-MalherbeH.AxelrodJ.TomchickR. (1959). Blood-Brain Barrier for Adrenaline.Science1291226–1227. 10.1126/science.129.3357.1226
142
WellerJ.BudsonA. (2018). Current understanding of Alzheimer’s disease diagnosis and treatment [version 1; referees: 2 approved].F1000Research7:F1000 Faculty Rev-1161. 10.12688/f1000research.14506.1.
143
WeymarM.LöwA.MelzigC. A.HammA. O. (2009). Enhanced long-term recollection for emotional pictures: Evidence from high-density ERPs.Psychophysiology461200–1207. 10.1111/j.1469-8986.2009.00869.x
144
WeymarM.LöwA.ModessC.EngelG.GründlingM.PetersmannA.et al (2010). Propranolol selectively blocks the enhanced parietal old/new effect during long-term recollection of unpleasant pictures: A high density ERP study.Neuroimage492800–2806. 10.1016/j.neuroimage.2009.10.025
145
WeymarM.SchwabeL.LöwA.HammA. O. (2012). Stress sensitizes the brain: Increased processing of unpleasant pictures after exposure to acute stress.J. Cogn. Neurosci.241511–1518. 10.1162/jocn_a_00174
146
WixtedJ. T.StretchV. (2004). In defense of the signal detection interpretation of remember/know judgments.Psychon. Bull. Rev.11616–641. 10.3758/BF03196616
147
YakuninaN.KimS. S.NamE.-C. (2017). Optimization of transcutaneous vagus nerve stimulation using functional MRI.Neuromodulat. Technol. Neural Interface20290–300. 10.1111/ner.12541
Summary
Keywords
vagus nerve stimulation, emotional memory, associative memory, fear extinction, Alzheimer’s disease, PTSD - Posttraumatic stress disorder, anxiety disorders, mild cognitive impairment - MCI
Citation
Szeska C, Ventura-Bort C, Giraudier M and Weymar M (2025) A vagal route to memory: evidence from invasive and non-invasive electrical vagus nerve stimulation studies and areas for future clinical application. Front. Hum. Neurosci. 19:1595737. doi: 10.3389/fnhum.2025.1595737
Received
18 March 2025
Accepted
17 June 2025
Published
08 July 2025
Volume
19 - 2025
Edited by
Leonardo L. Gollo, Monash University, Australia
Reviewed by
Bruno Bonaz, Centre Hospitalier Universitaire de Grenoble, France
Sophie Clementine Payne, Bionics Institute, Australia
Updates
Copyright
© 2025 Szeska, Ventura-Bort, Giraudier and Weymar.
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Christoph Szeska, christoph.szeska@uni-potsdam.deMathias Weymar, mathias.weymar@uni-potsdam.de
Disclaimer
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.